Share Purchase Agreement Terms Founders Should Negotiate

A headline acquisition price rarely means that full amount lands in a founder's bank account. Preferred investors get paid first, fees and debt come off the top, and a working capital adjustment nudges the number up or down before common stockholders, mostly founders, see a dollar of it. Even a liquidation preference that looks founder-friendly only changes the investor's choice inside that order, not the order itself. A 1x non-participating structure means the investor takes its money back or converts to common stock, never both. But if the sale price is at or below the total preference stack, preferred still eats first from the whole pot, and common stockholders split whatever crumbs fall off the table. M&A Considerations for Founders puts it bluntly: a founder can own most of the equity on paper and still walk away with almost nothing. That's the part of the deal nobody puts in the press release, and it's the reason the real negotiation happens in a handful of specific clauses, not in the number everyone toasts at the signing dinner. Before any serious buyer conversation starts, pull the charter, list every liquidation preference stacked on top of the common stock, and run the payout at the offer price and at a price meaningfully lower than that. That math tells a founder which offers actually pay out and which ones just sound good in a headline. And the fix has a deadline attached to it: once the letter of intent is signed, the exclusivity clause kicks in, leverage over price and structure mostly evaporates, and the buyer starts treating the headline number as a ceiling to chip away at during diligence.

The LOI and exclusivity period set the terms a founder lives with

The letter of intent itself is mostly non-binding paper. The exclusivity clause buried inside it is not. Signing that clause shuts down the competitive process and hands away the founder's strongest source of leverage at the exact moment price, structure, and the key terms are still up for discussion. Once exclusivity is signed, the buyer knows there's nowhere else for the founder to go. The buyer treats the agreed price as a ceiling from that point forward and uses whatever diligence turns up to push the number down from there. Sellers rarely claw that ground back, because the leverage that would move the price back up left the room the moment the pen touched paper. Agreeing to an exclusivity window longer than 30 days shuts the door on running any kind of competitive process, and without other buyers in the wings, negotiating position gets weaker every single day the clock runs. The fix is procedural: get counsel involved before the LOI is signed, while the exclusivity period, the fiduciary-out provision, and the price are all still things that can move. Signing locks all three at once.

Deal structure: stock sale, merger, or asset sale

The structure of the deal gets decided inside the LOI, often before a founder has fully clocked that it's happening. But the consequences of that choice, mainly the tax bill, can dwarf anything a lawyer later wins back on indemnity caps or escrow. A tax advisor needs a seat at the table while the structure is still a choice, not after it's been baked into a signed letter. A stock sale or a forward merger taxes the founder once, as capital gain, and clears the business's liabilities off the founder's plate in the process. For the seller, that structure creates a double tax problem: the corporate level gets taxed under Section 11, and then the proceeds get taxed again once they're distributed to stockholders. An asset sale also strands the QSBS exclusion, because Section 1202 only shelters the gain on the stock itself. A merger under DGCL Section 251 needs board approval plus a majority of outstanding shares, usually collected through written consent at a private company. Dissenters may have appraisal rights under Section 262, though most venture-backed companies waive those rights in the stockholders' agreement, and Delaware courts uphold those waivers.

The 83(b) election and QSBS, the formation-stage decisions behind a founder's tax outcome

For founders running Delaware C-corps, the default setup for nearly every US venture-backed startup, the 83(b) election and Section 1202 QSBS treatment are two halves of the same decision. Get both right at formation, and the door opens to the most valuable tax benefit a founder can claim at exit. Founder shares typically vest on a reverse-vesting structure: the founder owns 100 percent of the issued shares from day one, while the company holds a repurchase right that lapses on the vesting schedule. That structure is what makes the 83(b) election possible in the first place, letting a founder lock in tax basis at near-zero value at incorporation instead of paying tax on each vesting date as the shares become unrestricted. The deadline on that election is 30 days from the date of grant. It's a statutory deadline, the IRS has consistently refused to grant late relief, and the Tax Court has backed that refusal every time it's been tested. There's no extension, and there's no fix once the window closes. Missing the 83(b) on a venture-stage company with a long runway to exit exposes the founder to ordinary income tax on every vesting date, plus the loss of Section 1202 treatment on any shares that vest after year one. For plenty of successful exits, that single missed deadline is the largest avoidable tax loss of a founder's career. QSBS itself, under Section 1202 as modified by the One Big Beautiful Bill Act, now runs on a tiered holding period. Stock held between three and four years qualifies for a 50 percent gain exclusion. Five years or more gets the full 100 percent exclusion. The per-taxpayer cap on that exclusion is now $15 million, up from $10 million, and the gross assets threshold for a qualifying company is now $75 million, up from $50 million. A 2025 change made this benefit potentially far more valuable than it used to be. The structure a founder chooses at formation carries more weight now than it did a few years back.

Vesting schedules and acceleration clauses, what founders negotiate

A four-year vesting schedule with a one-year cliff is the industry's opening offer, not a law of physics. Founders with a pre-incorporation track record, returning founders, or co-founders bringing in meaningful assets on day one have grounds to negotiate a backdated vesting commencement date that credits the months of work already put in, rather than starting a fresh four-year clock at signing. The cliff itself means no shares vest until the founder has stuck around for twelve months. The clause founders tend to misread sits in acceleration on a change of control. Single-trigger acceleration, where 100 percent of unvested shares vest the moment the deal closes, sounds great for the founder on paper. Double-trigger acceleration is the realistic target, the real negotiation lives inside its definitions, and one place to push is extending the post-change-of-control window to 18 months. Narrow the definition of "cause" as tightly as the buyer will allow. Broaden "good reason" to cover material changes to role, compensation, or location, not just an outright firing. Those definitions decide whether the clause protects the founder or just looks like it does.

Liquidation preferences and anti-dilution, the investor terms founders can push back on

The liquidation preference decides who gets paid first and how much in any exit, and it shapes a founder's actual outcome more than the pre-money valuation ever will. It's also the term most routinely waved through by founders too focused on the number at the top of the deck. The market benchmark as of Q2 2026 is a 1x non-participating liquidation preference paired with broad-based weighted average anti-dilution. Anything that goes beyond that standard counts as aggressive, and founders have a factual basis for saying so at the table. A participating preferred structure lets investors take their preference back and then turn around and share in whatever proceeds are left, alongside the common stockholders. That double-dip can gut founder returns at exit, and whether it's in the deal or not is a binary question worth fighting over at the term sheet stage, long before the SPA gets drafted. Anti-dilution provisions kick in to protect investors when new shares get issued at a lower price in a down round. Full ratchet anti-dilution punishes founders far more severely than the weighted average formulas that represent the market standard, and any move toward full ratchet deserves direct pushback, backed by the benchmark above. Board composition runs on the same logic. Founder-friendly deals keep investors from holding a board majority at Seed or Series A, because losing that control early limits a founder's ability to steer decisions through every round that follows. Before signing anything, run the payout waterfall across at least three exit scenarios. Running the payout waterfall shows what a participating preferred structure actually costs compared to a non-participating one at different sale prices.

Representations, warranties, indemnification caps, and escrow

Representations and warranties are the factual statements a founder makes to the buyer about the state of the company. If one of those statements turns out to be false, the indemnification clause decides how much that mistake costs the founder personally. Three variables bound that exposure: the cap, the basket, and the survival period, and all three are negotiable even though founders often treat only the cap as worth fighting over. The cap sets the ceiling on post-closing liability. The basket sets the floor a claim has to clear before the buyer can bring it. The survival period sets the clock on how long the buyer has to bring a claim. Negotiating only the cap and leaving the other two alone is like locking the front door and leaving the windows open. How much money sits in escrow, and for how long, depends heavily on whether the deal carries representations and warranties insurance. SRS Acquiom's 2026 deal terms study found the median escrow on an uninsured deal ran materially larger than on an insured one, making RWI insurance a real lever for shrinking that holdback worth raising directly with advisors. Survival periods typically run 18 to 36 months after closing. Push for the shorter end of that range, and push harder for different survival lengths depending on the category of representation. Fundamental reps, like title to the shares and authority to sell them, can reasonably survive longer without creating exposure on the operational stuff that should wrap up sooner. Covenants round out this risk surface: promises about what the founder will or won't do between signing and closing, and sometimes after. Some are standard, like keeping the business running in the ordinary course. Others create exposure a founder wouldn't expect, so catching those requires reading every line closely.

Non-compete scope, duration, and geography

A Delaware ruling made the point concrete: courts enforce what a non-compete document actually says, not what a founder assumed it meant when they signed it. The non-compete a founder signs as the seller is a personal constraint, one that follows them home long after the buyer's wire transfer has cleared. Its scope, duration, and geography decide how long a founder is locked out of the exact industry they just spent years building expertise in. Courts hold founders to every word of that clause. The negotiating posture has to match the stakes. A court will read the geographic scope, the duration, and the definition of "restricted business" literally. Push the geographic scope to match where the company actually operates at the time of signing, not some aspirational map of markets it hopes to enter someday. Define "restricted business" narrowly and specifically, because vague language produces the widest, most painful restrictions down the line. The Delaware ruling is a reminder of what happens when that assumption turns out to be wrong.

How to sequence the negotiation before leverage disappears

The strongest negotiating position isn't the most exhaustive one. Showing up with three or four specific term changes signals that a founder understands market norms and isn't trying to rewrite the whole deal from scratch. A fully marked-up document, every page covered in redlines, reads as bad faith and burns goodwill without buying proportionate gains. Terms negotiate better as a package than in isolation. Trade concessions on the lower-priority items for wins on the ones that actually move the outcome, accepting standard indemnification baskets, for instance, in exchange for locking in a 1x non-participating liquidation preference. Decide the non-negotiables before that first conversation ever happens: liquidation preference structure, acceleration triggers and their definitions, the indemnification cap, and non-compete scope are the terms to hold firm on. Everything else has room to move. An attorney experienced specifically in venture M&A transactions is the baseline, not a nice-to-have, and founders who negotiate these agreements without that kind of specialized counsel consistently give up ground they wouldn't give up otherwise. Buyers probe every number they're given, and a founder who already understands their working capital cycle, EBITDA adjustments, and customer concentration risk before being asked negotiates from a position buyers can't easily chip away at. Every term covered here is fully negotiable right up until the LOI gets signed. Founders who understand these clauses before the first serious conversation close better deals, and founders who learn them for the first time during diligence are negotiating from a weaker position with every day that passes.